Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a720dd9179eb183a9026a2dbb9087448 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e96496a9949403e2af2ca913e65bfec http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53e48632daa9d1a799e88ee84f05531a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_773797413c847b0e64ceddba039b0d3e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1d7583f1931f6b8065de4ae62bc52cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c046a74f3f098464004f62854684abb2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a90baf3681e373a5b041c0fb7ef6c872 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-34 |
filingDate |
2012-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bdc71dbdb16cbf6c4b2becbac07fb09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35334065fe4d82c46d8c27d47f3e45ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8349fa76c4bca58a382cecc045829c96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3892a4d29e226040ee3ba0763b7835c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a47b6f55c65b23e9eecd7c1ac3bff8c0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1332236987cd0549cf186d05165d4dd |
publicationDate |
2014-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8642282-B2 |
titleOfInvention |
Inhibitors of nitric oxide synthase for treatment of melanoma |
abstract |
Methods for melanoma treatment and prevention with selective nitric oxide synthase inhibitor compounds and related pharmaceutical compositions, alone or in conjunction with one or more other melanoma therapies. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9090589-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11439632-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014147920-A1 |
priorityDate |
2011-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |